Stock Detail
HAEMONETICS CORPORATION
Sector: Indices SP 600
Latest Quote @ Wed Jun 6 01:41:38 (15 min delayed)
| N/A |
N/A |
$42.71 |
+0.41 |
0.97% |
|
Last Day's Data
| $42.71 |
$42.87 |
$0.41 |
0.97% |
0.00 |
$42.30 |
| $42.42 |
$42.36 |
525,943.00 |
2.18B |
311,982.00 |
57.61 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 43.16 |
42.94 |
42.65 |
42.43 |
42.14 |
Stock Profile
Haemonetics Corporation engages in the design, manufacture, and marketing of automated systems and single-use disposables for the collection, processing, and surgical salvage of donor and patient blood. The company's systems enable users to collect and process the blood component they target, such as plasma, platelets, or red blood cells. Its products include PCS brand systems, which automate the collection of plasma from donors; MCS, which automate the collection of platelets; ACP that automate the process used to freeze, thaw, and wash red blood cells. The company's surgical blood salvage systems are used during and after surgery to collect a patient's own blood for reinfusion. These systems include Cell Saver brand systems for higher blood loss surgeries and trauma; OrthoPAT brand systems for lower, slower blood loss procedures; and cardioPAT brand system for blood loss during and after beating heart surgeries or for blood loss after various coronary artery bypass graft surgeries. The company offers its products primarily through direct sales force, independent distributors, and agents principally in the United Sates, Europe, and Japan and other parts of Asia. Haemonetics was founded in 1971 and is based in Braintree, Massachusetts.
